Evidence map›Paper›PMID 31554195›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Interaction of Immune Cells and Tumor Cells in Gold Nanorod-Gelatin Composite Porous Scaffolds.

Xiuhui Wang, Naoki Kawazoe, Guoping Chen

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiuhui WangTissue Regeneration Materials Group, Research Center for Functional Materials, National Institute for Materials Science, Tsukuba, Ibaraki 305-0044, Japan. WANG.Xiuhui@nims.go.jp.ORCID 0000-0002-6031-0380
Naoki KawazoeTissue Regeneration Materials Group, Research Center for Functional Materials, National Institute for Materials Science, Tsukuba, Ibaraki 305-0044, Japan. KAWAZOE.Naoki@nims.go.jp.
Guoping ChenTissue Regeneration Materials Group, Research Center for Functional Materials, National Institute for Materials Science, Tsukuba, Ibaraki 305-0044, Japan. Guoping.CHEN@nims.go.jp.ORCID 0000-0001-6753-3678

Funding

Japan Society for the Promotion of Science 19H04475 and 18K19945
6 · The paper itself

Abstract

Composite porous scaffolds prepared by immobilization of photothermal nano-agents into porous scaffold have been used for both cancer therapy and tissue regeneration. However, it is not clear how the host immune cells and ablated tumor cells interact and stimulate each other in the composite scaffolds. In this research, a gold nanorod-incorporated gelatin composite scaffold with controlled spherical large pores and well interconnected small pores was fabricated by using ice particulates as a porogen. The composite porous scaffold was used for investigating the interaction between dendritic cells and photothermally ablated breast tumor cells. The composite scaffold demonstrated excellent photothermal property and the temperature change value could be adjusted by irradiation time and laser power density. The composite scaffold showed excellent photothermal ablation ability towards breast tumor cells. The photothermally ablated tumor cells induced activation of dendritic cells when immature dendritic cells were co-cultured in the composite scaffold. Consequently, the gold nanorod-incorporated gelatin composite porous scaffold should provide a useful platform for simultaneous photothermal-immune ablation of breast tumor.

Indexed as

cancer therapycell interactioncomposite scaffoldsgelatingold nanorodsimmune responsesphotothermal ablation

Identifiers

PMID31554195
PMCPMC6836150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.